Clinical Report: Evaluation of Responses from Publicly Available Large Language Models to Common Inquiries Regarding Spondylodiscitis

Background

Spondylodiscitis is a rare but serious infectious condition that affects the spine, leading to significant morbidity and potential complications. Its incidence is increasing, particularly among the aging population.

Data Highlights

No numerical or trial data was provided in the source material, which limits the comprehensiveness of the report.

Key Findings

• Spondylodiscitis accounts for 3% to 5% of all infectious bone diseases.
• The incidence of spondylodiscitis is rising, with absolute case numbers in Germany increasing from 6886 in 2010 to 9753 in 2020.
• In-hospital mortality for spondylodiscitis is reported at 17.2% within the first year after diagnosis.
• Patients often seek additional information online, which can be inconsistent and complex.
• Large language models can generate accessible health information but require careful evaluation for accuracy.

Clinical Implications

Healthcare providers should be aware of the increasing incidence of spondylodiscitis and the potential for misinformation from online sources. It is important to guide patients in seeking reliable health information, particularly when using AI tools.

Conclusion

The evaluation of LLM responses to inquiries about spondylodiscitis underscores the importance of ensuring the accuracy of health information provided to patients. Continuous assessment of these tools is necessary to enhance patient education.

Related Resources & Content

1. Gouliouris T, Aliyu SH, Brown NM, J Antimicrob Chemother, 2010 -- Spondylodiscitis: update on diagnosis and management
2. Lang S, Walter N, Schindler M, et al., J Clin Med, 2023 -- The epidemiology of spondylodiscitis in Germany: a descriptive report of incidence rates, pathogens, in-hospital mortality, and hospital stays between 2010 and 2020
3. Schindler M, Walter N, Reinhard J, et al., Front Surg, 2024 -- Midterm survival and risk factor analysis in patients with pyogenic vertebral osteomyelitis: a retrospective study of 155 cases
4. Yu D, Kang Y, Lu W, Chen B, EFORT Open Rev, 2025 -- Progress in diagnosis and treatment of primary spondylodiscitis: a systematic literature review
5. Infection — Impact of Microbiological Diagnosis on the Clinical Progression of Spondylodiscitis
6. Infection — Evaluating the Diagnostic Efficacy of MRI Versus 18F-FDG-PET/CT in Cases of Suspected Spondylodiscitis
7. npj Digital Medicine — Utilizing Multi-Agent Systems for Early Detection of Axial Spondyloarthritis in Primary Care Settings
8. Clinical Rheumatology — Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?
9. IDSA 2015 Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults
10. Spondylodiscitis: a call for unified guidelines
11. Diagnostik und Therapie der Spondylodiszitis | AWMF
12. https://acnmonline.org/common/Uploaded%20files/Web/Clinical%20Practice/Procedure%20Standards/2024/EANM%20SNMMI%20Guideline%20FDG%20Infection%20and%20Inflammation_SNMMI%20BOD%20FINAL.pdf
13. NHSN BJI Checklist
14. The bacterial spectrum of spinal infections based on blood culture, tissue culture, and molecular methods: a systematic review and meta-analysis | Scientific Reports
15. Network meta-analysis of antibiotic exposure and holiday duration, biopsy site, imaging guidance, and sampling approach on culture yield in vertebral osteomyelitis - ScienceDirect
16. EOR-2025-0041 815..828
17. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial - PubMed
18. 710 Oral Antibiotics Are Non-Inferior to Intravenous Therapy for Bone and Joint Infections: A Systematic Review and Meta-Analysis to Inform Surgical Practice | BJS | Oxford Academic
19. Early shift to oral antibiotic treatment for pyogenic vertebral osteomyelitis (SAVE): study protocol for an open label, non-inferiority, nation-wide randomized controlled clinical trial | Trials | Springer Nature Link